Update on genetic risk factors for thrombosis and atherosclerotic vascular disease

Hematology/Oncology Clinics of North America

Volumn 12, Issue 6, 1998, Pages 1193-1209

  Neufeld, E J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A; METHYLENETETRAHYDROFOLIC ACID; PROTHROMBIN;

ALLELE; AMINO ACID SUBSTITUTION; ARTERY THROMBOSIS; ATHEROSCLEROSIS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; THROMBOSIS; VASCULAR DISEASE;

EID: 0032425522     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70049-6     Document Type: Article

References (73)

1. V.R. Arruda L.H. Siquiera L.C. Chiaparini Prevalence of the prothrombin gene variant 20210 G to A among patients with myocardial infarction Cardiovasc Res 37 1998 42 45
2. G. Assmann P. Cullen J. Heinrich H. Schulte Hemostatic variables in the prediction of coronary risk: Results of the 8 year follow-up of healthy men in the Munster Heart Study (PROCAM). Prospective Cardiovascular Munster Study Isr J Med Sci 32 1996 364 370
3. R. Baumgartner H. Wick H. Ohnacker Vascular lesions in two patients with congenital homocystinuria due to different defects of remethylation J Inherit Metab Dis 3 1980 101 103
4. V. Biousse J. Conard C. Brouzes Frequency of the 20210 G to A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis Stroke 29 1998 1398 1400
5. E. Boerwinkle C.C. Leffert J. Lin Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations J Clin Invest 90 1992 52 60
6. N.W. Boonmark R.M. Lawn The lysine-binding function of Lp(a) Clin Genet 52 1997 355 360
7. K. Brown R. Luddington D. Williamson Risk of venous thromboembolism associated with a g to a transition at position 20210 in the 3′-untranslated region of the prothrombin gene Br J Haematol 98 1997 907 909
8. P. Bucciarelli F. Franchi A. Alatri Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene [letter] Thromb Haemost 79 1998 445 446
9. J.C. Cohen G. Chiesa H.H. Hobbs Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels J Clin Invest 91 1993 1630 1636
10. A. Corral R. Gonzalezconejero M.L. Lozano The venous thrombosis risk factor 20210 a allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease Br J Haematol 99 1997 304 307
11. J. Corral R. Gonzalezconejero M.L. Lozano Genetic polymorphisms of factor VII are not associated with arterial thrombosis Blood Coagul Fibrinolysis 9 1998 267 272
12. J. Corral J.A. Iniesta R. Gonzalezconejero Migraine and prothrombotic genetic risk factors Cephalalgia 18 1998 257 260
13. M.P. de Maat F. Green P. de Knijff Factor VII polymorphisms in populations with different risks of cardiovascular disease [published erratum appears in Arterioscler Thromb Vasc Biol 17:3646, 1997] Arterioscler Thromb Vasc Biol 17 1997 1918 1923
14. M. den Heijer T. Koster H.J. Blom Hyperhomocysteinemia as a risk factor for deep-vein thrombosis N Engl J Med 334 1996 759 762
15. V. De Stefano P. Chiusolo K. Paciaroni Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients Blood 91 1998 3562 3565
16. C.J. Doggen V.M. Cats R.M. Bertina F.R. Rosendaal Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A Circulation 97 1998 1037 1041
17. S. Ehrenforth G. Ludwig S. Klinke The prothrombin 20210 a allele is frequently coinherited in young carriers of the factor V arg 506 to gln mutation with venous thrombophilia Blood 91 1998 2209 2210
18. P. Ferraresi G. Marchetti C. Legnani The heterozygous 20210 g/a prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease Arterioscler Thromb Vasc Biol 17 1997 2418 2422
19. D. Gemmati M.L. Serino S. Moratelli Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family Blood Coagul Fibrinolysis 9 1998 173 176
20. J. Haan L.J. Kappelle M.D. Ferrari R.M. Bertina The transition g to a at position 20210 in the 3′-untranslated region of the prothrombin gene is not associated with migrainous infarction Cephalalgia 18 1998 229 230
21. K.A. Hajjar R.L. Nachman The role of lipoprotein(a) in atherogenesis and thrombosis [review] Annu Rev Med 47 1996 423 442
22. L.A. Harker J.M. Harlan R. Ross Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons Circ Res 53 1983 731 739
23. D.M. Heywood A.M. Carter A.J. Catto Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality Stroke 28 1997 816 821
24. A. Hillarp B. Zoller P.J. Svensson B. Dahlback The 20210 a allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis Thromb Haemost 78 1997 990 992
25. J. Holm T. Todt E. Berntorp L. Erhardt Failure of thrombolytic therapy in patients with myocardial infarction is associated with high plasma levels of factor VII antigen Thromb Haemost 79 1998 928 931
26. T.E. Howard M. Marusa C. Channell A. Duncan A patient homozygous for a mutation in the prothrombin gene 3′-untranslated region associated with massive thrombosis Blood Coagul Fibrinolysis 8 1997 316 319
27. M. Hunault A.A. Arbini S. Lopaciuk The arg(353)gln polymorphism reduces the level of coagulation factor VII—in vivo and in vitro studies Arterioscler Thromb Vasc Biol 17 1997 2825 2829
28. L. Iacoviello A. Di Castelnuovo P. De Knijff Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction N Engl J Med 338 1998 79 85
29. A. Ichinose E.W. Davie The bood coagulation factors: Their cDNAs, genes, and expression R.W. Colman J. Hirsh V.J. Marder E.W. Salzman Thrombosis and Hemostasis ed 3 1994 JB Lippincott Philadelphia 19 54
30. A.B. Irish F.R. Green Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: Relationship with dyslipidaemia, inflammation, and factor VII genotype Nephrology, Dialysis, Transplantation 13 1998 679 684
31. R. Junker J. Heinrich H. Schulte Coagulation factor VII and the risk of coronary heart disease in healthy men Arterioscler Thromb Vasc Biol 17 1997 1539 1544
32. S.S. Kang P.W. Wong J.M. Zhou Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease Metabolism 37 1988 611 613
33. Y.S. Kanwar J.R. Manaligod P.W. Wong Morphologic studies in a patient with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency Pediatr Res 10 1976 598 609
34. A. Lane F. Green P.Y. Scarabin Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study Atherosclerosis 119 1996 119 127
35. C. Legnani G. Palareti F. Grauso Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (ala(223)val mthfr) in patients with inherited thrombophilic coagulation defects Arterioscler Thromb Vasc Biol 17 1997 2924 2929
36. S.R. Lentz C.G. Sobey D.J. Piegors Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia J Clin Invest 98 1996 24 29
37. C. Leroyer B. Mercier E. Oger Prevalence of 20210 a allele of the prothrombin gene in venous thromboembolism patients Thromb Haemost 80 1998 49 51
38. M. Makris F.E. Preston N.J. Beauchamp Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia Thromb Haemost 78 1997 1426 1429
39. M. Makris F.R. Rosendaal F.E. Preston Familial thrombophilia—genetic risk factors and management J Intern Med 242 1997 9 15
40. S.M. Marcovina M.L. Koschinsky Lipoprotein(a): Structure, measurement, and clinical significance N. Rifai G.R. Warnick M.H. Dominiczak Handbook of Lipoprotein Testing 1997 AACC Press Washington, DC 283 313
41. I. Martinelli E. Sacchi G. Landi High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives N Engl J Med 338 1998 1793 1797
42. K.S. McCully Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
43. K.S. McCully Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: A key case revisited Nutr Rev 50 1992 7 12
44. K.S. McCully R.B. Wilson Homocysteine theory of arteriosclerosis Atherosclerosis 22 1975 215 227
45. T.W. Meade S. Mellows M. Brozovic Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study Lancet 2 1986 533 537
46. L.I. Mennen J.C. Witteman J.H. den Breeijen The association of dietary fat and fiber with coagulation factor VII in the elderly: The Rotterdam Study Am J Clin Nutr 65 1997 732 736
47. G.D. Minno E. Grandone M. Margaglione Clinical relevance of polymorphic markers of arterial thrombosis Thromb Haemost 78 1997 462 466
48. S.H. Mudd H.L. Levy F. Skovby Disorders of transsulfuration C.R. Scriver A.L. Beauded W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease ed 7 1995 McGraw-Hill New York 1279 1328
49. S. Nishiuma K. Kario K. Nakanishi Factor VII r353q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls Blood Coagul Fibrinolysis 8 1997 525 530
50. O. Nygard S.E. Vollset H. Refsum Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study JAMA 274 1995 1526 1533
51. J.M. Petaja J.H. Griffin Activated protein C resistance: What have we learned now that the dust has settled? [editorial] Ann Med 29 1997 469 472
52. S.R. Poort F.R. Rosendaal P.H. Reitsma R.M. Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
53. V.L. Prenger T.H. Beaty P.O. Kwiterovich Genetic determination of high-density lipoprotein cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients Am J Hum Genet 51 1992 1047 1057
54. H. Refsum P.M. Ueland O. Nygard S.E. Vollset Homocysteine and cardiovascular disease. [review] Annu Rev Med 49 1998 31 62
55. 6 from diet and supplements in relation to risk of coronary heart disease among women JAMA 279 1998 359 364
56. F.R. Rosendaal C.J. Doggen A. Zivelin Geographic distribution of the 20210 G to A prothrombin variant Thromb Haemost 79 1998 706 708
57. F.R. Rosendaal D.S. Siscovick S.M. Schwartz A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women Blood 90 1997 1747 1750
58. N. Rosenthal R.S. Schwartz In search of perverse polymorphisms N Engl J Med 338 1998 122 124
59. A.M. Scanu Lipoprotein(a): A genetic risk factor for premature coronary heart disease JAMA 267 1992 3326 3329
60. J.S. Stamler J.A. Osborne O. Jaraki Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J Clin Invest 91 1993 308 318
61. M.J. Stampfer M.R. Malinow W.C. Willett A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians JAMA 268 1992 877 881
62. J.H. Stein R.S. Rosenson Lipoprotein Lp(a) excess and coronary heart disease [review] Arch Intern Med 157 1997 1170 1176
63. S. Tonstad H. Refsum M. Sivertsen Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives Pediatr Res 40 1996 47 52
64. S. Tonstad H. Refsum P.M. Ueland Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia Circulation 96 1997 1803 1808
65. G. Utermann Lipoprotein(a) C.R. Scriver A.L. Beauded W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease ed 7 1995 McGraw-Hill New York 1887 1912
66. E.M. Van Cott M. Laposata Laboratory evaluation of hypercoagulable states Hematol Oncol Clin North Am 12 1998 1141 1166
67. P.N. Varelas B.J. Sleight H.M. Rinder Stroke in a neonate heterozygous for factor V Leiden Pediatr Neurol 18 1998 262 264
68. P. Verhoef M.J. Stampfer E.B. Rimm Folate and coronary heart disease [review] Curr Opinion Lipidol 9 1998 17 22
69. X.L. Wang J. Wang R.M. McCredie D.E. Wilcken Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease Arterioscler Thromb Vasc Biol 17 1997 246 251
70. H.H. Watzke J. Schuttrumpf S. Graf Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease Thromb Res 87 1997 521 526
71. M. Weih S. Mehraein J.M. Valdueza Coincidence of factor V Leiden mutation and a mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous thrombosis Stroke 29 1998 1739 1740
72. G.N. Welch J. Loscalzo Homocysteine and atherothrombosis [review] N Engl J Med 338 1998 1042 1050
73. B. Zoller P. Garcia de Frutos B. Dahlback A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency Thromb Haemost 79 1998 802 807